Risk Factors for Operation Complications of High Dose Rate 3-Dimensional Interstitial Brachytherapy for Lung Cancer
Clinical Lung Cancer · 2023
DOI: 10.1016/j.cllc.2023.04.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lung Cancer, 2023. Verfasst von Xiaoyue Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Pneumothorax, Brachytherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: The risk factors for operation complications of high-dose-rate dimensional (3D) interstitial brachytherapy for lung malignant tumors are still unclear. We aimed to provide a reliable reference for the preoperative safety assessment of interstitial brachytherapy. PATIENTS AND METHODS: We analyzed the degree and incidence of operational complications in 120 eligible patients with lung carcinoma who underwent computed tomography (CT)-guided HDR interstitial brachytherapy. Univariate and multivariate analyses were used to study the relationships between patient-related factors, tumor-related factors, operation-related factors, and operational complications. RESULTS: The most frequent complications of CT-guided HDR interstitial brachytherapy were pneumothorax and hemorrhage. In univariate analysis, smoking, emphysema, distance of implanted needles through the normal lung tissue, number of implanted needle adjustments, and distance of the lesion from the pleura were the risk factors for pneumothorax; the tumor size, distance of the tumor from the pleura, number of implanted needle adjustments, and distance of the implanted needle through the normal lung tissue were risk factors for hemorrhage. In multivariate analysis, the depth of the implanted needle through the normal lung tissue and distance of the lesion from the pleura were independent risk factors for pneumothorax. Tumor size, number of implanted needle adjustments, and distance through normal lung tissue were independent risk factors for hemorrhage. CONCLUSION: This study provides a reference for the clinical treatment of lung cancer by analyzing the risk factors for complications of interstitial brachytherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China.
- Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China. Electronic address: wjb6147@163.com.
- Department of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, China. Electronic address: xl790927@sina.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, X., Zhou, H., Mou, K., Zheng, Y., Li, H., Ren, P., Ye, H., Lin, S., Pang, H., Wu, J., & Xiang, L. (2023). Risk Factors for Operation Complications of High Dose Rate 3-Dimensional Interstitial Brachytherapy for Lung Cancer. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2023.04.003
Vancouver
Li X, Zhou H, Mou K, Zheng Y, Li H, Ren P, et al. Risk Factors for Operation Complications of High Dose Rate 3-Dimensional Interstitial Brachytherapy for Lung Cancer. Clinical Lung Cancer. 2023. doi:10.1016/j.cllc.2023.04.003
BibTeX
@article{Li2023,
author = {Li, Xiaoyue and Zhou, Huan and Mou, Kelin and Zheng, Yun and Li, Hongxia and Ren, Peirong and Ye, Hua and Lin, Sheng and Pang, Haowen and Wu, Jingbo and Xiang, Li},
title = {Risk Factors for Operation Complications of High Dose Rate 3-Dimensional Interstitial Brachytherapy for Lung Cancer},
journal = {Clinical Lung Cancer},
year = {2023},
doi = {10.1016/j.cllc.2023.04.003}
}
EUVIMED